These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10629005)

  • 21. Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review.
    Falagas ME; Tansarli GS; Kapaskelis A; Vardakas KZ
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):69-78. PubMed ID: 23428103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Lee CS; Lee JS; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing carbapenem-resistant Gram-negative bacilli and decreasing metallo-β-lactamase producers over eight years from Korea.
    Lee Y; Kim CK; Chung HS; Yong D; Jeong SH; Lee K; Chong Y
    Yonsei Med J; 2015 Mar; 56(2):572-7. PubMed ID: 25684011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain.
    Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp].
    Sacha P; Wieczorek P; Jakoniuk P; Zórawski M
    Wiad Lek; 2008; 61(1-3):30-6. PubMed ID: 18717040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenem-resistant gram-negative bacilli in Tripoli, Libya.
    Kraiem AG; Zorgani A; Elahmer O; El Salabi AA; Ghenghesh KS
    Am J Infect Control; 2016 Oct; 44(10):1192-1194. PubMed ID: 27473769
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and antibacterial activity of 2alpha-functionalized 1beta-methylcarbapenems related to KR-21012.
    Kwak HJ; Pyun DK; Kim JH; Kim EJ; Jeong HJ; Kim BJ; Lee CH
    Bioorg Med Chem Lett; 2000 Feb; 10(4):333-6. PubMed ID: 10714493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa.
    Matsumoto T; Kumazawa J; Nagayama A
    J Antimicrob Chemother; 1996 Aug; 38(2):322-4. PubMed ID: 8877553
    [No Abstract]   [Full Text] [Related]  

  • 33. Newer carbapenems for urinary tract infections.
    Matsumoto T; Muratani T
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel 1beta-methylcarbapenems having a new moiety at C-2.
    Kang YK; Shin KJ; Yoo KH; Seo KJ; Park SY; Kim DJ; Park SW
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2385-90. PubMed ID: 10476874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and antimicrobial assessment of 2-thioether-linked quinolonyl-carbapenems.
    Hershberger PM; Switzer AG; Yelm KE; Coleman MC; Devries CA; Rourke FJ; Davis BW; Kraft WG; Twinem TL; Koenigs PM; Paule SM; Siehnel RJ; Zoutendam PH; Imbus R; Demuth TP
    J Antibiot (Tokyo); 1998 Sep; 51(9):857-71. PubMed ID: 9820237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.
    Colardyn F
    Acta Clin Belg; 2005; 60(2):51-62. PubMed ID: 16082989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A; Jungwirth R; Schweighart S
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
    Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
    Dong SX; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2012 Dec; 45(6):459-64. PubMed ID: 23102796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.